Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease
NCT03350165Phase 2Completed
- Sponsor
- Kowa Company, Ltd.
- Start
- Dec 2017
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemafibrate in non-alcoholic fatty liver disease (NAFLD), sponsored by Kowa Company, Ltd.. Started Dec 2017; status: completed.
02
Drugs
pemafibrate
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT03350165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03350165.